Decision

Advertising investigations: February 2015

Decisions made by MHRA following an investigation into complaints about advertising for licensed medicines.

• From: Medicines and Healthcare products Regulatory Agency
• Published: 27 April 2015

Documents

February 2015: clinics advertising botulinum toxin products

HTML

Details

Contact advertising@mhra.gsi.gov.uk if you have concerns with the advertising of medicines or write to:

Advertising Standards Unit,
151 Buckingham Palace Road,
Victoria,
London SW1W 9SZ.

Alternatively, contact the pharmaceutical self-regulatory bodies, the Proprietary Association of Great Britain (PAGB) for advertising for over the counter medicines, or the Prescription Medicines Code of Practice Authority (PMCPA) for advertisements to health professionals for prescription medicines.

Published 27 April 2015